Robins Harlan S
Chief Scientific Officer at ADPT
- Sold, on record
- $63.2M
- Dollars the filings state
- Form 4 sales
- 42
- Latest Jul 21, 2026
- Form 144 notices
- 20
- Proposed sales
- Quarters with a sale
- 6 of the last 8
- 13 days with a sale in that time
- Companies
- 1
- Filed as an executive or holder
Companies
- ADPTAdaptive Biotechnologies CorpChief Scientific Officer
Sales by reason
8
Routine
13
Plan not stated
1
No plan
20
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Aug 20, 2026Notice
Filed a notice to sell 402,160 shares
$10.2M402,160 shares
- Aug 19, 2026Notice
Filed a notice to sell 215,632 shares
$5.5M215,632 shares
- Aug 18, 2026Notice
Filed a notice to sell 261,044 shares
$6.4M261,044 shares
- Aug 17, 2026Notice
Filed a notice to sell 300,992 shares
$7.5M300,992 shares
- Jul 21, 2026Unusual
Sold 37.7% of their holdings
$10.8M492,400 shares at $21.89
- Jul 21, 2026Notice
Filed a notice to sell 492,400 shares
$11.1M492,400 shares
- Jul 2, 2026Unusual
Sold 27.5% of their holdings
$8.5M386,240 shares at $22.01
- Jul 2, 2026Notice
Filed a notice to sell 386,240 shares
$8.2M386,240 shares
- Jun 16, 2026Unusual
Sold 7% of their holdings
$1.8M106,160 shares at $17.41
- Jun 16, 2026Notice
Filed a notice to sell 6,160 shares
$106k6,160 shares
10 of 62
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Jul 23, 2026 | ADPT | Chief Scientific Officer | Sold | 492,400 | $21.89 | $10.8M | 812,058 | SEC |
| Jul 21, 2026 | Jul 23, 2026 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (right to buy) | 284,800 | 0 | SEC | ||
| Jul 21, 2026 | Jul 23, 2026 | ADPT | Chief Scientific Officer | Exercised options | 284,800 | $6.55 | $1.9M | 1.3M | SEC |
| Jul 2, 2026 | Jul 7, 2026 | ADPT | Chief Scientific Officer | Sold | 386,240 | $22.01 | $8.5M | 1M | SEC |
| Jun 16, 2026 | Jun 17, 2026 | ADPT | Chief Scientific Officer | Sold | 106,160 | $17.41 | $1.8M | 1.4M | SEC |
| Apr 8, 2026 | Apr 10, 2026 | ADPT | Chief Scientific Officer | Sold | 10,000 | $14.85 | $149k | 1.5M | SEC |
| Mar 11, 2026 | Mar 13, 2026 | ADPT | Chief Scientific Officer | Sold | 470,266 | $13.17 | $6.2M | 1.5M | SEC |
| Mar 6, 2026 | Mar 6, 2026 | ADPT | Chief Scientific Officer | Awarded | 837,033 | 2M | SEC | ||
| Mar 3, 2026 | Mar 4, 2026 | ADPT | Chief Scientific Officer | Sold | 24,233 | $16.19 | $392k | 1.2M | SEC |
| Feb 3, 2026 | Feb 4, 2026 | ADPT | Chief Scientific Officer | Sold | 42,788 | $18.68 | $799k | 1.2M | SEC |
| Jan 6, 2026 | Jan 8, 2026 | ADPT | Chief Scientific Officer | Sold | 10,000 | $16.44 | $164k | 1.2M | SEC |
| Dec 4, 2025 | Dec 5, 2025 | ADPT | Chief Scientific Officer | Sold | 37,212 | $18.07 | $673k | 1.2M | SEC |
| Nov 10, 2025 | Nov 12, 2025 | ADPT | Chief Scientific Officer | Sold | 10,000 | $14.82 | $148k | 1.3M | SEC |
| May 1, 2025 | May 5, 2025 | ADPT | Chief Scientific Officer | Sold | 68,412 | $7.35 | $503k | 1.3M | SEC |
| May 1, 2025 | May 5, 2025 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 68,412 | 0 | SEC | ||
| May 1, 2025 | May 5, 2025 | ADPT | Chief Scientific Officer | Exercised options | 68,412 | $6.32 | $432k | 1.3M | SEC |
| Mar 24, 2025 | Mar 26, 2025 | ADPT | Chief Scientific Officer | Sold | 1,698 | $9.00 | $15k | 1.3M | SEC |
| Mar 24, 2025 | Mar 26, 2025 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 1,698 | 68,412 | SEC | ||
| Mar 24, 2025 | Mar 26, 2025 | ADPT | Chief Scientific Officer | Exercised options | 1,698 | $6.32 | $11k | 1.3M | SEC |
| Mar 5, 2025 | Mar 6, 2025 | ADPT | Chief Scientific Officer | Sold | 96,656 | $6.99 | $675k | 1.3M | SEC |
| Mar 4, 2025 | Mar 6, 2025 | ADPT | Chief Scientific Officer | Awarded | 355,000 | 1.4M | SEC | ||
| Mar 4, 2024 | Mar 6, 2024 | ADPT | Chief Scientific Officer | Awarded | 354,610 | 1M | SEC | ||
| Mar 6, 2023 | Mar 8, 2023 | ADPT | Chief Scientific Officer | Awarded | 354,610 | 666,570 | SEC | ||
| Mar 7, 2022 | Mar 8, 2022 | ADPT | Chief Scientific Officer | Sold | 4,517 | $12.01 | $54k | 311,960 | SEC |
| Mar 4, 2022 | Mar 8, 2022 | ADPT | Chief Scientific Officer | AwardedStock Option (Right to Buy) | 617,792 | 617,792 | SEC | ||
| Mar 4, 2022 | Mar 8, 2022 | ADPT | Chief Scientific Officer | Awarded | 247,117 | 316,477 | SEC | ||
| Nov 18, 2021 | Nov 19, 2021 | ADPT | Chief Scientific Officer | Sold | 4,000 | $32.00 | $128k | 69,360 | SEC |
| Nov 18, 2021 | Nov 19, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 4,000 | 284,800 | SEC | ||
| Nov 18, 2021 | Nov 19, 2021 | ADPT | Chief Scientific Officer | Exercised options | 4,000 | $6.55 | $26k | 69,660 | SEC |
| Oct 21, 2021 | Oct 21, 2021 | ADPT | Chief Scientific Officer | Sold | 11,200 | $33.71 | $378k | 69,360 | SEC |
| Oct 21, 2021 | Oct 21, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,200 | 288,800 | SEC | ||
| Oct 21, 2021 | Oct 21, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,200 | $6.55 | $73k | 73,060 | SEC |
| Oct 8, 2021 | Oct 8, 2021 | ADPT | Chief Scientific Officer | Sold | 11,685 | $32.95 | $385k | 69,360 | SEC |
| Oct 8, 2021 | Oct 8, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,685 | 70,110 | SEC | ||
| Oct 8, 2021 | Oct 8, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,685 | $6.32 | $74k | 73,255 | SEC |
| Sep 15, 2021 | Sep 15, 2021 | ADPT | Chief Scientific Officer | Sold | 11,685 | $36.98 | $432k | 69,360 | SEC |
| Sep 15, 2021 | Sep 15, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,685 | 81,795 | SEC | ||
| Sep 15, 2021 | Sep 15, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,685 | $6.32 | $74k | 73,255 | SEC |
| Aug 27, 2021 | Aug 27, 2021 | ADPT | Chief Scientific Officer | Sold | 11,685 | $34.25 | $400k | 69,360 | SEC |
| Aug 27, 2021 | Aug 27, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,685 | 93,480 | SEC | ||
| Aug 27, 2021 | Aug 27, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,685 | $6.32 | $74k | 73,255 | SEC |
| Jul 21, 2021 | Jul 21, 2021 | ADPT | Chief Scientific Officer | Sold | 11,685 | $37.47 | $438k | 69,360 | SEC |
| Jul 21, 2021 | Jul 21, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,685 | 105,165 | SEC | ||
| Jul 21, 2021 | Jul 21, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,685 | $6.32 | $74k | 73,255 | SEC |
| Jun 11, 2021 | Jun 11, 2021 | ADPT | Chief Scientific Officer | Sold | 11,685 | $37.32 | $436k | 69,360 | SEC |
| Jun 11, 2021 | Jun 11, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 11,685 | 116,850 | SEC | ||
| Jun 11, 2021 | Jun 11, 2021 | ADPT | Chief Scientific Officer | Exercised options | 11,685 | $6.32 | $74k | 73,255 | SEC |
| May 6, 2021 | May 7, 2021 | ADPT | Chief Scientific Officer | Sold | 7,090 | $35.58 | $252k | 69,360 | SEC |
| May 6, 2021 | May 7, 2021 | ADPT | Chief Scientific Officer | Exercised or settledStock Option (Right to Buy) | 7,790 | 128,535 | SEC | ||
| May 6, 2021 | May 7, 2021 | ADPT | Chief Scientific Officer | Exercised options | 7,790 | $6.32 | $49k | 73,255 | SEC |
Page 1
Sales and notices (62)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Aug 20, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 402,160 | $10.2M | Notice | SEC | |
| Aug 19, 2026 | Aug 19, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 215,632 | $5.5M | Notice | SEC | |
| Aug 18, 2026 | Aug 18, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 261,044 | $6.4M | Notice | SEC | |
| Aug 17, 2026 | Aug 17, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 300,992 | $7.5M | Notice | SEC | |
| Jul 21, 2026 | Jul 23, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 492,400 | $10.8M | 37.7% | Unusual | SEC |
| Jul 21, 2026 | Jul 21, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 492,400 | $11.1M | Notice | SEC | |
| Jul 2, 2026 | Jul 7, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 386,240 | $8.5M | 27.5% | Unusual | SEC |
| Jul 2, 2026 | Jul 2, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 386,240 | $8.2M | Notice | SEC | |
| Jun 16, 2026 | Jun 17, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 106,160 | $1.8M | 7.0% | Unusual | SEC |
| Jun 16, 2026 | Jun 16, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 6,160 | $106k | Notice | SEC | |
| Jun 15, 2026 | Jun 15, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 100,000 | $1.7M | Notice | SEC | |
| Apr 8, 2026 | Apr 10, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 10,000 | $149k | 0.7% | Routine | SEC |
| Apr 8, 2026 | Apr 8, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 10,000 | $148k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 470,266 | $6.8M | Notice | SEC | |
| Mar 11, 2026 | Mar 13, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 470,266 | $6.2M | 23.6% | Unusual | SEC |
| Mar 3, 2026 | Mar 4, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 24,233 | $392k | 2.1% | Routine | SEC |
| Mar 3, 2026 | Mar 3, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 14,233 | $229k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 10,000 | $161k | Notice | SEC | |
| Feb 3, 2026 | Feb 4, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 42,788 | $799k | 3.5% | Routine | SEC |
| Feb 3, 2026 | Feb 3, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 8,120 | $150k | Notice | SEC | |
| Feb 2, 2026 | Feb 2, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 34,668 | $638k | Notice | SEC | |
| Jan 6, 2026 | Jan 8, 2026 | ADPT | Chief Scientific Officer | Form 4 sale | 10,000 | $164k | 0.8% | Routine | SEC |
| Jan 6, 2026 | Jan 6, 2026 | ADPT | Chief Scientific Officer | Form 144 notice | 10,000 | $161k | Notice | SEC | |
| Dec 4, 2025 | Dec 5, 2025 | ADPT | Chief Scientific Officer | Form 4 sale | 37,212 | $673k | 2.9% | Routine | SEC |
| Dec 4, 2025 | Dec 4, 2025 | ADPT | Chief Scientific Officer | Form 144 notice | 10,000 | $175k | Notice | SEC | |
| Dec 3, 2025 | Dec 3, 2025 | ADPT | Chief Scientific Officer | Form 144 notice | 27,212 | $466k | Notice | SEC | |
| Nov 10, 2025 | Nov 12, 2025 | ADPT | Chief Scientific Officer | Form 4 sale | 10,000 | $148k | 0.8% | Routine | SEC |
| Nov 10, 2025 | Nov 10, 2025 | ADPT | Chief Scientific Officer | Form 144 notice | 10,000 | $147k | Notice | SEC | |
| May 1, 2025 | May 5, 2025 | ADPT | Chief Scientific Officer | Form 4 sale | 68,412 | $503k | 5.1% | Routine | SEC |
| May 1, 2025 | May 1, 2025 | ADPT | Chief Scientific Officer | Form 144 notice | 68,412 | $504k | Notice | SEC | |
| Mar 24, 2025 | Mar 26, 2025 | ADPT | Chief Scientific Officer | Form 4 sale | 1,698 | $15k | 0.1% | Routine | SEC |
| Mar 24, 2025 | Mar 24, 2025 | ADPT | Chief Scientific Officer | Form 144 notice | 1,698 | $15k | Notice | SEC | |
| Mar 5, 2025 | Mar 6, 2025 | ADPT | Chief Scientific Officer | Form 4 sale | 96,656 | $675k | 7.0% | No plan | SEC |
| Mar 7, 2022 | Mar 8, 2022 | ADPT | Chief Scientific Officer | Form 4 sale | 4,517 | $54k | 1.4% | Plan not stated | SEC |
| Nov 18, 2021 | Nov 19, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 4,000 | $128k | 5.5% | Plan not stated | SEC |
| Oct 21, 2021 | Oct 21, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,200 | $378k | 13.9% | Plan not stated | SEC |
| Oct 8, 2021 | Oct 8, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,685 | $385k | 14.4% | Plan not stated | SEC |
| Sep 15, 2021 | Sep 15, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,685 | $432k | 14.4% | Plan not stated | SEC |
| Aug 27, 2021 | Aug 27, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,685 | $400k | 14.4% | Plan not stated | SEC |
| Jul 21, 2021 | Jul 21, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,685 | $438k | 14.4% | Plan not stated | SEC |
| Jun 11, 2021 | Jun 11, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 11,685 | $436k | 14.4% | Plan not stated | SEC |
| May 6, 2021 | May 7, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 7,090 | $252k | 9.3% | Plan not stated | SEC |
| May 4, 2021 | May 6, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 3,895 | $141k | 5.3% | Plan not stated | SEC |
| Apr 22, 2021 | Apr 22, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 27,265 | $1.1M | 28.2% | Unusual | SEC |
| Mar 25, 2021 | Mar 25, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 19,475 | $786k | 21.9% | Plan not stated | SEC |
| Feb 3, 2021 | Feb 5, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 7,790 | $464k | 92.0% | Unusual | SEC |
| Feb 2, 2021 | Feb 3, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 15,580 | $900k | 95.8% | Unusual | SEC |
| Jan 21, 2021 | Jan 25, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 23,370 | $1.6M | 97.2% | Unusual | SEC |
| Jan 20, 2021 | Jan 21, 2021 | ADPT | Chief Scientific Officer | Form 4 sale | 100,000 | $6.8M | 99.3% | Unusual | SEC |
| Nov 6, 2020 | Nov 6, 2020 | ADPT | Chief Scientific Officer | Form 4 sale | 33,300 | $1.7M | 98.0% | Unusual | SEC |
Showing the first 50